-
1
-
-
0035873477
-
Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate
-
Blann, A.D., F.M. Belgore, J. Constans, C. Conri and G.Y. Lip, 2001. Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. Am. J. Cardiol. 8710: 1160-1163.
-
(2001)
Am. J. Cardiol
, vol.8710
, pp. 1160-1163
-
-
Blann, A.D.1
Belgore, F.M.2
Constans, J.3
Conri, C.4
Lip, G.Y.5
-
2
-
-
0030938919
-
Vascular endothelial growth factor/vascular permeability factor VEGF/VPF. in normal and atherosclerotic human arteries
-
Couffinhal, T., M. Kearney, B. Witzenbichler, D. Chen, T. Murohara, D.W. Losordo, J. Symes and J.M. Isner, 1997. Vascular endothelial growth factor/vascular permeability factor VEGF/VPF. in normal and atherosclerotic human arteries. Am. J. Pathol., 1505: 1673-1685.
-
(1997)
Am. J. Pathol
, vol.1505
, pp. 1673-1685
-
-
Couffinhal, T.1
Kearney, M.2
Witzenbichler, B.3
Chen, D.4
Murohara, T.5
Losordo, D.W.6
Symes, J.7
Isner, J.M.8
-
3
-
-
33646708058
-
Simvastatin reduces serum level of vascular endothelial growth factor in hypercholesterolemic patients
-
Giurgea, A.G., C. Margeta, T. Maca, A. Rezaie-Majd, R.A. Bucek, M. Manavi, R. Afarideh, E. Minar and M. Baghestanian, 2006. Simvastatin reduces serum level of vascular endothelial growth factor in hypercholesterolemic patients. J. Cardiovasc Pharmacol., 471: 30-36.
-
(2006)
J. Cardiovasc Pharmacol
, vol.471
, pp. 30-36
-
-
Giurgea, A.G.1
Margeta, C.2
Maca, T.3
Rezaie-Majd, A.4
Bucek, R.A.5
Manavi, M.6
Afarideh, R.7
Minar, E.8
Baghestanian, M.9
-
4
-
-
0034739554
-
-
Hiltunen, M.O., M. Laitinen, M.P. Turunen, M. Jeltsch, J. Hartikainen, T.T. Rissanen, J. Laukkanen, M. Niemi, M. Kossila, T.P. Hakkinen, A. Kivela, B. Enholm, H. Mansukoski, A.M. Turunen, K. Alitalo and S. Yla-Herttuala, 2000. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation, 10218: 2262-2268.
-
Hiltunen, M.O., M. Laitinen, M.P. Turunen, M. Jeltsch, J. Hartikainen, T.T. Rissanen, J. Laukkanen, M. Niemi, M. Kossila, T.P. Hakkinen, A. Kivela, B. Enholm, H. Mansukoski, A.M. Turunen, K. Alitalo and S. Yla-Herttuala, 2000. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation, 10218: 2262-2268.
-
-
-
-
5
-
-
20544434319
-
VEGF polymorphisms and severity of atherosclerosis
-
Howell, W.M., S. Ali, M.J. Rose-Zerilli and S. Ye, 2005. VEGF polymorphisms and severity of atherosclerosis. J. Med. Genet., 426: 485-490.
-
(2005)
J. Med. Genet
, vol.426
, pp. 485-490
-
-
Howell, W.M.1
Ali, S.2
Rose-Zerilli, M.J.3
Ye, S.4
-
6
-
-
0032542072
-
Vascular endothelial growth factor VEGF. Expression in human coronary atherosclerotic lesions: Possible pathophysiol. significance of VEGF in progression of atherosclerosis
-
Inoue, M., H. Itoh, M. Ueda, T. Naruko, A. Kojima, R. Komatsu, K. Doi, Y. Ogawa, N. Tamura, K. Takaya, T. Igaki, J. Yamashita, T.H. Chun, K. Masatsugu, A.E. Becker and K. Nakao, 1998. Vascular endothelial growth factor VEGF. Expression in human coronary atherosclerotic lesions: Possible pathophysiol. significance of VEGF in progression of atherosclerosis. Circulation, 9820: 2108-2116.
-
(1998)
Circulation
, vol.9820
, pp. 2108-2116
-
-
Inoue, M.1
Itoh, H.2
Ueda, M.3
Naruko, T.4
Kojima, A.5
Komatsu, R.6
Doi, K.7
Ogawa, Y.8
Tamura, N.9
Takaya, K.10
Igaki, T.11
Yamashita, J.12
Chun, T.H.13
Masatsugu, K.14
Becker, A.E.15
Nakao, K.16
-
7
-
-
0035025911
-
VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor
-
Kuzuya, M., M.A. Ramos, S. Kanda, T. Koike, T. Asai, K. Maeda, K. Shitara, M. Shibuya and A. Iguchi, 2001. VEGF protects against oxidized LDL toxicity to endothelial cells by an intracellular glutathione-dependent mechanism through the KDR receptor. Arterioscler Thromb Vasc Biol, 215: 765-770.
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.215
, pp. 765-770
-
-
Kuzuya, M.1
Ramos, M.A.2
Kanda, S.3
Koike, T.4
Asai, T.5
Maeda, K.6
Shitara, K.7
Shibuya, M.8
Iguchi, A.9
-
8
-
-
0030669594
-
VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries
-
Laitinen, M., I. Zachary, G. Breier, T. Pakkanen, T. Hakkinen, J. Luoma, H. Abedi, W. Risau, M. Soma, M. Laakso, J.F. Martin and S. Yla-Herttuala, 1997. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum. Gene Ther., 815: 1737-1744.
-
(1997)
Hum. Gene Ther
, vol.815
, pp. 1737-1744
-
-
Laitinen, M.1
Zachary, I.2
Breier, G.3
Pakkanen, T.4
Hakkinen, T.5
Luoma, J.6
Abedi, H.7
Risau, W.8
Soma, M.9
Laakso, M.10
Martin, J.F.11
Yla-Herttuala, S.12
-
9
-
-
24644458573
-
Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein - receptor/apolipoprotein B48 - deficient mice
-
Leppanen, P., S. Koota, I. Kholova, J. Koponen, C. Fieber, U. Eriksson, K. Alitalo and S. Yla-Herttuala, 2005. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein - receptor/apolipoprotein B48 - deficient mice. Circulation, 1129: 1347-1352.
-
(2005)
Circulation
, vol.1129
, pp. 1347-1352
-
-
Leppanen, P.1
Koota, S.2
Kholova, I.3
Koponen, J.4
Fieber, C.5
Eriksson, U.6
Alitalo, K.7
Yla-Herttuala, S.8
-
10
-
-
12144291703
-
Oral imatinib mesylate ST1571/gleevec. improves the efficacy of local intravascular vascular endothelial growth factor - C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits
-
Leppanen, O., J. Rutanen, M.O. Hiltunen, T.T. Rissanen, M.P. Turunen, T. Sjoblom, J. Bruggen, G. Backstrom, M. Carlsson, E. Buchdunger, D. Bergqvist, K. Alitalo, C.H. Heldin, A. Ostman and S. Yla-Herttuala, 2004. Oral imatinib mesylate ST1571/gleevec. improves the efficacy of local intravascular vascular endothelial growth factor - C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits. Circulation, 1099: 1140-1146.
-
(2004)
Circulation
, vol.1099
, pp. 1140-1146
-
-
Leppanen, O.1
Rutanen, J.2
Hiltunen, M.O.3
Rissanen, T.T.4
Turunen, M.P.5
Sjoblom, T.6
Bruggen, J.7
Backstrom, G.8
Carlsson, M.9
Buchdunger, E.10
Bergqvist, D.11
Alitalo, K.12
Heldin, C.H.13
Ostman, A.14
Yla-Herttuala, S.15
-
11
-
-
0037180771
-
-
Libby, P., 2002. Inflammation in atherosclerosis. Nature. 4206917: 868-874.
-
Libby, P., 2002. Inflammation in atherosclerosis. Nature. 4206917: 868-874.
-
-
-
-
12
-
-
12344266849
-
Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL
-
Rodriguez, J.A., B. Nespereira, M. Perez-Ilzarbe, E. Eguinoa and J.A. Paramo, 2005. Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL. Cardiovasc Res., 653: 665-673.
-
(2005)
Cardiovasc Res
, vol.653
, pp. 665-673
-
-
Rodriguez, J.A.1
Nespereira, B.2
Perez-Ilzarbe, M.3
Eguinoa, E.4
Paramo, J.A.5
-
13
-
-
12144290557
-
Vascular endothelial growth factor-D expression in human atherosclerotic lesions
-
Rutanen, J., P. Leppanen, T.T. Tuomisto, T.T. Rissanen, M.O. Hiltunen, I. Vajanto, M. Niemi, T. Hakkinen, K. Karkola, S.A. Stacker, M.G. Achen, K. Alitalo and S. Yla-Herttuala, 2003. Vascular endothelial growth factor-D expression in human atherosclerotic lesions. Cardiovasc Res., 594: 971-979.
-
(2003)
Cardiovasc Res
, vol.594
, pp. 971-979
-
-
Rutanen, J.1
Leppanen, P.2
Tuomisto, T.T.3
Rissanen, T.T.4
Hiltunen, M.O.5
Vajanto, I.6
Niemi, M.7
Hakkinen, T.8
Karkola, K.9
Stacker, S.A.10
Achen, M.G.11
Alitalo, K.12
Yla-Herttuala, S.13
-
14
-
-
21344445050
-
Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism
-
Rutanen, J., A.M. Turunen, M. Teittinen, T.T. Rissanen, T. Heikura, J.K. Koponen, M. Gruchala, M. Inkala, S. Jauhiainen, M.O. Hiltunen, M.P. Turunen, S.A. Stacker, M.G. Achen and S. Yla - Herttuala, 2005. Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism. Gene Ther., 1212: 980-987.
-
(2005)
Gene Ther
, vol.1212
, pp. 980-987
-
-
Rutanen, J.1
Turunen, A.M.2
Teittinen, M.3
Rissanen, T.T.4
Heikura, T.5
Koponen, J.K.6
Gruchala, M.7
Inkala, M.8
Jauhiainen, S.9
Hiltunen, M.O.10
Turunen, M.P.11
Stacker, S.A.12
Achen, M.G.13
Yla - Herttuala, S.14
-
15
-
-
0035003384
-
Structure and function of VEGF/VEGF-receptor system involved in angiogenesis
-
Shibuya, M., 2001. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct., 261: 25-35.
-
(2001)
Cell Struct Funct
, vol.261
, pp. 25-35
-
-
Shibuya, M.1
-
16
-
-
33745728426
-
Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients
-
Trape, J., C. Morales, R. Molina, X. Filella, J.M. Marcos, R. Salinas and J. Franquesa, 2006. Vascular endothelial growth factor serum concentrations in hypercholesterolemic patients. Scand J. Clin. Lab. Invest., 663: 261-267.
-
(2006)
Scand J. Clin. Lab. Invest
, vol.663
, pp. 261-267
-
-
Trape, J.1
Morales, C.2
Molina, R.3
Filella, X.4
Marcos, J.M.5
Salinas, R.6
Franquesa, J.7
-
17
-
-
0030745193
-
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity
-
Tsurumi, Y., T. Murohara, K. Krasinski, D. Chen, B. Witzenbichler, M. Kearney, T. Couffinhal and J.M. Isner, 1997. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat. Med., 38: 879-886.
-
(1997)
Nat. Med
, vol.38
, pp. 879-886
-
-
Tsurumi, Y.1
Murohara, T.2
Krasinski, K.3
Chen, D.4
Witzenbichler, B.5
Kearney, M.6
Couffinhal, T.7
Isner, J.M.8
-
18
-
-
33644871364
-
Influence of cardiovascular risk factors on endothelial progenitor cells: Limitations for therapy?
-
Werner, N. and G. Nickenig, 2006. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol., 262: 257-266.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.262
, pp. 257-266
-
-
Werner, N.1
Nickenig, G.2
-
19
-
-
33847421319
-
Vascular endothelial growth factors: Biology and current status of clinical applications in cardiovascular medicine
-
Yla-Herttuala, S., T.T. Rissanen, I. Vajanto and J. Hartikainen, 2007. Vascular endothelial growth factors: Biology and current status of clinical applications in cardiovascular medicine. J. Am. Coll. Cardiol,. 4910: 1015-1026.
-
(2007)
J. Am. Coll. Cardiol
, vol.4910
, pp. 1015-1026
-
-
Yla-Herttuala, S.1
Rissanen, T.T.2
Vajanto, I.3
Hartikainen, J.4
-
20
-
-
0348049834
-
-
Zachary, I., 2003. VEGF signalling: Integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans., 31Pt, 6: 1171-1177.
-
Zachary, I., 2003. VEGF signalling: Integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans., 31Pt, 6: 1171-1177.
-
-
-
|